secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0000010795-24-000024
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD Life Sciences President Dave Hickey to retire effective July 1, 2024
-----------------------------------------------------------------------

- Dave Hickey, EVP and President of Life Sciences segment, announced retirement effective July 1, 2024.
- Hickey held the role since January 2021; previously president of Integrated Diagnostic Solutions and Diagnostic Systems.
- BD intends to name a successor prior to his retirement date.
- Hickey joined BD in 2014 and led development of rapid and molecular COVID-19 diagnostic tests.
- No financial or guidance changes disclosed in connection with the retirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000001079524000024/0000010795-24-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000001079524000024/bdx-20240222.htm
  HTML page:      https://secwatch.observer/filing/0000010795-24-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer